Latest filing published 01 Sept 2023 for Ventyx Biosciences, Inc., €163k.
Filing timeline
BuySaleInsider track record
William J. Sandborn: trading record in brief
William J. Sandborn discloses dealings in Ventyx Biosciences, Inc. to SEC (Form 4). Over a trading history stretching from 14 December 2022 to 31 August 2023, the count stands at 29 filings.
Sales make up the whole of the open-market record (18 sales, €4.1M). Outside the open market, there are 11 option exercises. 2023 to date brings no purchases and 16 sales.
The latest filing, published on 1 September 2023, reports an open-market sale of €369k in Ventyx Biosciences, Inc. Typically, a trade is published a median of 2 days after it takes place. US insiders must file a Form 4 within two business days of a trade. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to William J. Sandborn
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 11,900 shares@ US$14.8525.6% of flowCommon StockSEC:0001209191-23-047971:0
- 2,086 shares@ US$32.68529.8% of flowCommon StockSEC:0001209191-23-045086:0
- 11,900 shares@ US$14.8525.3% of flowCommon StockSEC:0001209191-23-043963:0
- 11,900 shares@ US$14.8525.5% of flowCommon StockSEC:0001209191-23-041351:0
- 10,790 shares@ US$0.200.3% of flowCommon StockSEC:0001209191-23-039960:0
- 2,383 shares@ US$33.877411.6% of flowCommon StockSEC:0001209191-23-038188:0
- 10,629 shares@ US$0.200.3% of flowCommon StockSEC:0001209191-23-033401:0
- 3,272 shares@ US$0.200.1% of flowCommon StockSEC:0001209191-23-029961:0
- 10,790 shares@ US$0.200.3% of flowCommon StockSEC:0001209191-23-026312:0
- 2,391 shares@ US$3.541.3% of flowCommon StockSEC:0000899243-22-038836:0
10 of 10 declarations
